Table 3.
Association between patients’ comorbidities and drug intake and Cycle threshold values (Fisher's exact test).
| All patients |
Ct lower than median (n = 11) |
Ct higher than median (n = 14) |
p (Fisher) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tot | n | % | Tot | n | % | Tot | n | % | |||
| Sex | Males | 25 | 17 | 68 | 11 | 8 | 72.7 | 14 | 9 | 64.3 | 0.31 |
| Respiratory tract disorders | Lung/Mediastinal/Airways | 23 | 5 | 21.74 | 11 | 3 | 27.3 | 12 | 2 | 16.7 | 0.32 |
| Cardiovascular and dysmetabolic disorders | 23 | 15 | 65.22 | 11 | 7 | 63.6 | 12 | 8 | 66.7 | 0.33 | |
| Dyslipidemia | 23 | 7 | 30.43 | 11 | 4 | 36.4 | 12 | 3 | 25 | 0.30 | |
| Hypertension | 23 | 7 | 30.43 | 11 | 4 | 36.4 | 12 | 3 | 25 | 0.30 | |
| Obesity | 24 | 8 | 33.33 | 11 | 3 | 27.3 | 13 | 5 | 38.5 | 0.29 | |
| Drug intake | 20 | 8 | 40 | 9 | 5 | 55.6 | 11 | 3 | 27.3 | 0.17 | |
| Antihypertensives or Antiaggregants or Anticoagulants | 20 | 5 | 25 | 9 | 3 | 33.3 | 11 | 2 | 18.2 | 0.30 | |
| Ace-inhibitors or ARBs | 20 | 4 | 20 | 9 | 2 | 22.2 | 11 | 2 | 18.2 | 0.41 | |
| Statins | 20 | 5 | 25 | 9 | 3 | 33.3 | 11 | 2 | 182 | 0.30 | |